Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| BIJUVA | knight therapeutics inc. | Marketed | Jan 31, 2024 | Marketed |
| AG-CITALOPRAM TABLETS | angita pharma inc. | Marketed | Jan 30, 2024 | Marketed |
| EUCERIN AGE DEFENSE | beiersdorf canada inc | Marketed | Jan 30, 2024 | Marketed |
| EUCERIN COMPLETE HYDRATION LOTION | beiersdorf canada inc | Marketed | Jan 30, 2024 | Marketed |
| SANDOZ APREMILAST | Sandoz Canada, Inc. | Marketed | Jan 30, 2024 | Marketed |
| EUCERIN COMPLETE HYDRATION SPRAY | beiersdorf canada inc | Marketed | Jan 30, 2024 | Marketed |
| TESTOSTERONE ENANTHATE INJECTION, USP | hikma canada limited | Marketed | Jan 30, 2024 | Marketed |
| KETOROLAC TROMETHAMINE INJECTION USP | Jamp Pharma Corporation | Marketed | Jan 29, 2024 | Marketed |
| MYFEMBREE | Sumitomo Pharma Switzerland GmbH | Marketed | Jan 29, 2024 | Marketed |
| NYPOZI | TANVEX BIOPHARMA USA, INC. | Marketed | Jan 24, 2024 | Marketed |
| NYPOZI | TANVEX BIOPHARMA USA, INC. | Marketed | Jan 24, 2024 | Marketed |
| UV+AGE DAILY | vichy canada | Marketed | Jan 24, 2024 | Marketed |
| NRA-ARIPIPRAZOLE | nora pharma inc | Marketed | Jan 23, 2024 | Marketed |
| DEXLANSOPRAZOLE | altius healthcare inc | Cancelled Post Market | Jan 23, 2024 | Cancelled Po... |
| NRA-ARIPIPRAZOLE | nora pharma inc | Marketed | Jan 23, 2024 | Marketed |
| NRA-ARIPIPRAZOLE | nora pharma inc | Marketed | Jan 23, 2024 | Marketed |
| NRA-ARIPIPRAZOLE | nora pharma inc | Marketed | Jan 23, 2024 | Marketed |
| DEXLANSOPRAZOLE | altius healthcare inc | Cancelled Post Market | Jan 23, 2024 | Cancelled Po... |
| FUROSEMIDE INJECTION USP | Jamp Pharma Corporation | Marketed | Jan 23, 2024 | Marketed |
| ELREXFIO | Pfizer Canada Ulc | Marketed | Jan 23, 2024 | Marketed |
